98-23303. Natural Rubber-Containing Medical Devices; User Labeling; Cold Seal Adhesives Partial Stay  

  • [Federal Register Volume 63, Number 168 (Monday, August 31, 1998)]
    [Rules and Regulations]
    [Pages 46174-46175]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-23303]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    21 CFR Part 801
    
    [Docket No. 96N-0119]
    
    
    Natural Rubber-Containing Medical Devices; User Labeling; Cold 
    Seal Adhesives Partial Stay
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Final rule.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The final rule for user labeling requirements for natural 
    rubber-containing medical devices, 21 CFR 801.437, was published on 
    September 30, 1997, and becomes effective on September 30, 1998. The 
    Food and Drug Administration (FDA) is adding a note to that rule to 
    stay, for 270 days from the effective date, paragraphs (f) and (g) as 
    those final rule requirements relate to device packaging that uses 
    ``cold seal'' adhesives. Labeling changes required by other paragraphs 
    of this final rule must be incorporated in the labeling of devices
    
    [[Page 46175]]
    
    distributed after September 30, 1998, even if the devices are packaged 
    in ``cold seal'' packages. Device packaging that uses natural rubber 
    only on adhesives contained in the flaps of device packaging is not 
    considered subject to the rule. Manufacturers of devices packaged with 
    ``cold seal'' adhesives may, if necessary, submit a petition for an 
    extension of the 270-day stay.
    
    DATES: Effective September 30, 1998, until June 27, 1999.
    
    ADDRESSES: Submit written comments to the Dockets Management Branch 
    (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
    Rockville, MD 20852.
    
    FOR FURTHER INFORMATION CONTACT: John J. Farnham, Center for Devices 
    and Radiological Health (HFZ-332), Food and Drug Administration, 2098 
    Gaither Rd., Rockville, MD 20850, 301-594-4616.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of September 30, 
    1997 (62 FR 51021), FDA issued a final rule requiring labeling 
    statements on medical devices, including device packaging containing 
    natural rubber that contacts humans. The rule becomes effective on 
    September 30, 1998. On June 5, 1998, the Health Industry Manufacturers 
    Association (HIMA) filed a citizen petition requesting FDA to stay 
    implementation of the final rule as it pertains to adhesives used in 
    packaging, and packaging in general, of medical devices. On June 19, 
    1998, FDA denied the HIMA petition with respect to packaging in general 
    but stated FDA would grant a stay of the effective date of paragraphs 
    (f) and (g) of Sec. 801.437 for 270 days from the effective date of the 
    final rule as it pertains to device packaging that uses ``cold seal'' 
    adhesives. Labeling changes required by other paragraphs of the final 
    rule, such as elimination of the word ``hypoallergenic'' and inclusion 
    of the latex content statement for devices that have natural rubber in 
    places other than the packaging must be incorporated into the labeling 
    of devices distributed after September 30, 1998, even if those devices 
    are packaged in ``cold seal'' packages. The agency's response to HIMA's 
    petition also clarified that FDA does not consider device packaging 
    that uses natural rubber only on adhesives contained in the flaps of 
    device packaging to be subject to the rule because such adhesives are 
    not intended and are not likely to contact humans. The petition from 
    HIMA and the agency's response are available for public examination in 
    the Dockets Management Branch (address above) between 9 a.m. and 4 
    p.m., Monday through Friday. The agency's response is also available on 
    the FDA home page at http://www.fda.gov/cdrh.
        This action is being taken under FDA's authority under 21 CFR 
    10.35(a). The Commissioner finds that this stay is in the public 
    interest.
        Therefore, under the Federal Food, Drug, and Cosmetic Act, and 
    under authority delegated to the Commissioner of Food and Drugs, 21 CFR 
    part 801 is amended as follows:
    
    PART 801--LABELING
    
         1. The authority citation for 21 CFR part 801 continues to read as 
    follows:
        Authority: 21 U.S.C. 321, 331, 351, 352, 357, 360i, 360j, 371, 
    374.
    
         2. Section 801.437 is amended by adding the following note to the 
    end of the section:
    
    
    Sec. 801.437  User labeling for devices that contain natural rubber.
    
    *        *        *        *        *
        Note to Sec. 801.437: Paragraphs (f) and (g) are stayed until 
    June 27, 1999, as those regulations relate to device packaging that 
    uses ``cold seal'' adhesives.
    
        Dated: August 20, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-23303 Filed 8-28-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Effective Date:
9/30/1998
Published:
08/31/1998
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule.
Document Number:
98-23303
Dates:
Effective September 30, 1998, until June 27, 1999.
Pages:
46174-46175 (2 pages)
Docket Numbers:
Docket No. 96N-0119
PDF File:
98-23303.pdf
CFR: (1)
21 CFR 801.437